Role of NF-κβ and oxidative pathways in atherosclerosis: cross-talk between dyslipidemia and candesartan. [electronic resource]
Producer: 20140919Description: 381-7 p. digitalISSN:- 1755-5922
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Animals
- Atherosclerosis -- drug therapy
- Benzimidazoles -- pharmacology
- Biphenyl Compounds
- Cell Movement -- drug effects
- Chemokines -- analysis
- Cytokines -- analysis
- Dyslipidemias -- drug therapy
- Lipids -- blood
- Monocytes -- drug effects
- NF-kappa B -- physiology
- Oxidation-Reduction
- Rabbits
- Tetrazoles -- pharmacology
- Vascular Cell Adhesion Molecule-1 -- analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.